Results 241 to 250 of about 1,904,009 (281)

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Human nasal epithelial cells express IL-5Rα but not the co-receptor CSF2RB and do not signal to IL-5. [PDF]

Allergy
Sohail A, Cho L, Hacker J, Bergmark RW, Lee SE, Maxfield A, Roditi RE, Dwyer DF, Buchheit KM, Laidlaw TM.   +9 more
europepmc   +1 more source

IL-5 and its receptor.

Japanese Journal of Clinical Immunology, 1990
openaire   +2 more sources

Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer

Molecular Oncology, EarlyView.
Tumors contain diverse cellular states whose behavior is shaped by context‐dependent gene coordination. By comparing gene–gene relationships across biological contexts, we identify adaptive transcriptional modules that reorganize into distinct vulnerability axes.
Brian Nelson, Lyanne Delgado‐Coka, Natalia Marchenko, Luisa F. Escobar‐Hoyos, Kenneth R. Shroyer, Alisa Yurovsky, Trey Ideker, Gábor Balázsi, Thomas MacCarthy, Scott Powers   +9 more
wiley   +1 more source

Changes in IL-6, IL-12, IL-5, IL-10 and TGF-β1 Concentration in Patients with Treatment-Resistant Schizophrenia (TRS) Following Electroconvulsive Therapy (ECT)-A Pilot Study. [PDF]

Biomedicines
Szota AM, Radajewska I, Ćwiklińska-Jurkowska M, Lis K, Grudzka P, Dróżdż W.   +5 more
europepmc   +1 more source

Eosinophilic Meningoencephalitis Occurred during Oral Corticosteroid Tapering and after Switching from Anti-IL-5 to Anti-IgE Treatment. [PDF]

Intern Med
Nishii Y, Kinoshita T, Sasaki J, Tsuneyoshi S, Irie K, Tateishi T, Tominaga M, Taniwaki T, Hoshino T, Kawayama T.   +9 more
europepmc   +1 more source

Phenotypic Shift of an Inflammatory Eosinophil Subset into a Steady-State Resident Phenotype after 2 Years of Vaccination against IL-5 in Equine Insect Bite Hypersensitivity. [PDF]

Vet Sci
Schwarz E, Jebbawi F, Keller G, Rhiner T, Fricker A, Waldern N, Canonica F, Schoster A, Fettelschoss-Gabriel A.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

IL-5 and eosinophilia

Current Opinion in Immunology, 2008
While Interleukin-5 (IL-5) is initially identified by its ability to support the growth and differentiation of activated B cells, overexpression of IL-5 significantly increases eosinophil numbers and antibody levels predominantly from an expanded population of B-1 cells in vivo. Conversely, mice lacking a functional gene for IL-5 or IL-5 receptor alpha
Kiyoshi, Takatsu, Hiroshi, Nakajima
openaire   +2 more sources

New frontiers for IL-5

Journal of Allergy and Clinical Immunology, 1997
Part 1 ; Christopher J. Bagley, Angel F.
Bagley, C., Lopez, A., Vadas, M.
openaire   +3 more sources